Anti-HIV ribozymes
- 1 June 1997
- journal article
- review article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 7 (3) , 241-251
- https://doi.org/10.1007/bf02740815
Abstract
HIV is an RNA virus that replicates intracellularly through various RNA intermediates. Several of these can be targeted by ribozymes (catalytic RNA molecules), and a number of investigators, including this group, have demonstrated the ability of ribozymes to suppress HIV replication in this way. It is argued that this gene therapy approach may be viewed as an adjunct to chemotherapeutic drugs, which may allow not just viral suppression, but also immune restoration. This can only finally be tested in clinical trials, and several are planned. The basic ribozyme unit, the potential of which was described less than 10 years ago, is about to be tested in an amenable disease state.Keywords
This publication has 74 references indexed in Scilit:
- Clinical treatmentAIDS, 1996
- RevM10-Mediated Inhibition of HIV-1 Replication in Chronically Infected T CellsHuman Gene Therapy, 1995
- Gene therapy and immune restoration for HIV diseaseThe Lancet, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- RNA enzymes as tools for gene ablationCurrent Opinion in Biotechnology, 1995
- Transfer of an Anti-HIV-1 Ribozyme Gene into Primary Human LymphocytesHuman Gene Therapy, 1994
- Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1991
- High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-1 InfectionNew England Journal of Medicine, 1991
- Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected PersonsNew England Journal of Medicine, 1989